Journal of Biotechnology & Biomaterials
Open 91桃色
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open 91桃色 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open 91桃色 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Citations : 3330
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- ResearchBible
- China National Knowledge Infrastructure (CNKI)
- 91桃色 to Global Online Research in Agriculture (AGORA)
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
In Association with
Encapsulated mesenchymal stem cells promote local neoangiogenesis by a paracrine effect
Annual Conference and Expo on Biomaterials
Andrew Lewis
Biocompatibles UK Ltd, UK
ScientificTracks Abstracts: J Biotechnol Biomater
DOI:
Abstract
We have taken human mesenchymal stem cells (hMSCs) that have been genetically engineered to produce Glucagon-like Peptide-1 (GLP-1) fusion peptide and encapsulated them within an alginate microcapsule to provide immunoprotection (cell beads). The cell beads were evaluated in a range of models of cardiovascular disease in order to ascertain if the implanted cells could illicit a beneficial therapeutic effect through the secretion and localized release of paracrine factors from hMSCs. In models of Acute Myocardial Infarction (AMI), cell beads were infused intraarterially, in either a swine embolization model of left ventricular dysfunction or balloon occlusion models of moderate and severe acute myocardial infarction with histological analyses and effects on functional recovery compared with relevant controls. In a model of Vein Graft Disease (VGD), cell beads were applied periadventially around a swine vein-into-artery interposition graft and the effect on neointimal formation and adventitial angiogenesis evaluated. To evaluate potential application in Critical Limb Ischemia (CLI), the therapeutic activity of perivascular transplantation of cell beads was assessed in an immunocompetent mouse model of limb ischemia. In each of the models, implantation of the cell beads was associated with notable functional improvement due to sustained delivery of locoregional paracrine factors secreted from the hMSCs that supports the potential use of the technology in treatment of these disease states. Moreover, in each case there was an additional statistically significant increase in new blood vessels formation. This was identified as a consequence of Vascular Endothelial Growth Factor A (VEGF-A) secretion from the hMSCs.Biography
Andrew Lewis is the Director of R&D in Innovation at BTG. He specializes in the development of advanced biomedical polymer systems, for instance, to enhance the biocompatibility of implants or to modulate delivery of active agents in the body. He has published ~200 papers (H-index 46), 11 book chapters and 50 patent families/applications in the fields of polymers, biomaterials and drug delivery. He was recently awarded the Chapman Medal for distinguished research in the field of biomedical materials.
Email: andrew.lewis@btgplc.com
